Quanterix (QTRX) Restructuring Costs (2022 - 2023)

Quanterix (QTRX) reported Restructuring Costs of -$33000.0 for Q1 2023, down 110.03% quarter-over-quarter from $329000.0 in Q4 2022.

Quanterix (QTRX) Restructuring Costs (2022 - 2023) Analysis & Trends

Quanterix has reported Restructuring Costs for 2 years, with the latest figure at -$33000.0 in Q1 2023.

For the quarter ending Q1 2023, Restructuring Costs changed N/A year-over-year to -$33000.0; the trailing twelve-month figure through Jun 2023 stood at $3.7 million (changed N/A YoY), and the FY2022 full-year result was $3.8 million, changed N/A from the prior year.
Restructuring Costs for Q1 2023 stood at -$33000.0, down from $329000.0 in the prior quarter.
The five-year high for Restructuring Costs was $3.4 million in Q3 2022, with the low at -$33000.0 in Q1 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	Quanterix	159.26 Mn	59.99 Mn	15.57 Mn

Download Data